The Unitary Patent & Unified Patent Court conference – Friday June 28, Paris

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

The Unitary Patent & Unified Patent Court conference – Friday June 28, Paris

Expectations, wishes and fears: be part of an international focus group!

upcc202013.jpg

When will the unitary patent and court be operational? What are the traps on its way to the target? What will be in the rules of procedure for the UPC? What will it really cost for users? How will large companies strategically use the new system?

Get the scoops from Kestin Jorna (EU Commission), Yves Lapierre (INPI), Alexander Ramsay (Preparatory Committee), Jérôme Debrulle (EPO Select Committee), judges from six countries, economists, the Max Planck Institute, as well as industry experts at GSK, Teva, Bosch, Microsoft and Nokia.

Register now at www.premiercercle.com/upc



more from across site and SHARED ros bottom lb

More from across our site

The Texas-based IP litigation hires take King & Spalding’s partner appointments from pre-merger Winston & Strawn up to 12 this year
Sunny Su explains how her team overcame challenges with orchard evidence collection to secure a favourable plant variety decision from China’s top court
Flexible working firm continues trajectory from 2025 with appointment of Matthew Grant and Letao Qin
Anousha Davies, associate and trademark attorney at Birketts, unpicks how the university’s reputation enabled it to see off a proposed trademark for ‘Cambridge Rowing’
IP lawyers, who say they are encouraging clients to build up ‘tariff resilience’, should treat the risks posed by recent orders as a core consideration in cross-border licensing
Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
News of Via Licensing Alliance adding two new members and Nokia’s proposal to extend interim licences to Warner Bros Discovery and Paramount were also among the top talking points
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Cooley and Stikeman Elliott advised 35Pharma on the deal, which will allow GSK to get its hands on S235, an investigational medicine for pulmonary hypertension
Simon Wright explains why the UK should embrace the possibility of rejoining the UPC, and reveals how CIPA is reacting to this month’s historic Emotional Perception AI case at the UK Supreme Court
Gift this article